[JAMA] Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis

andy_bio Post time 2024-4-29 22:27:54 | Show all posts |Read mode
Reward10points

journal£ºJAMA Dermatology

Authors£ºAndrew Blauvelt

Published date£º2024-3-1

DOI£º10.1001/jamadermatol.2023.6198

PDF link£ºhttps://jamanetwork.com/journals ... 710184567.11169.pdf

Article link£ºhttp://dx.doi.org/10.1001/jamadermatol.2023.6198

Article Source£ºAmerican Medical Association (AMA)¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
kiancc Post time 2024-4-29 22:27:55 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    80

Same Category

Latest Reply

Return to the list